Aptorum Group Enters into an Agreement with Exeltis to Develop Aptorum's Novel Preclinical Candidate Targeting Woman's Gynecological Conditions
Stock Information for Aptorum Group Limited
Loading
Please wait while we load your information from QuoteMedia.